Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.80
+0.25 (2.37%)
May 8, 2026, 1:46 PM CST
Market Cap967.50M -23.5%
Revenue (ttm)364.79M +3.0%
Net Income28.05M +22.6%
EPS0.31 +24.0%
Shares Out90.00M
PE Ratio34.68
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume276,270
Average Volume358,590
Open10.55
Previous Close10.55
Day's Range10.45 - 11.05
52-Week Range9.51 - 17.65
Beta0.45
RSI47.24
Earnings DateMay 14, 2026

About TPEX:4186

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and op... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 165
Stock Exchange Taipei Exchange
Ticker Symbol 4186
Full Company Profile

Financial Performance

In 2025, TPEX:4186's revenue was 364.79 million, an increase of 3.00% compared to the previous year's 354.17 million. Earnings were 28.05 million, an increase of 22.61%.

Financial Statements